Outcomes From a Prospectively Implemented Protocol Using Apixaban After Robotic Radical Cystectomy.

Jordan Miller RichYuval ElkunJack GeduldigEtienne LavalleeReza MehrazinKyrollis AttallaPeter WiklundJohn P Sfakianos

Published in: BJU international (2023)

Prophylaxis with Apixaban and Enoxaparin showed no statistically significant differences in VTE rates among RARC patients. Apixaban appears safe and effective for VTE prophylaxis after RARC.

Keyphrases

venous thromboembolism
end stage renal disease
atrial fibrillation
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
randomized controlled trial
prognostic factors
patient reported outcomes